13 Pharmaceuticals Stocks to Sell Now

The ratings of 13 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More 

This Well-Known Dividend Giant Is On Sale (BMY)

If a Blue Chip stock drops 16% in one day, do you rush to buy? In the case of Bristol-Meyers, the answer is yes. Time to consider BMY stock More 

Bristol-Myers Squibb Co: The BMY Freefall Is Overdone

BMY stock has sustained a technical beatdown over the past couple of days. But Bristol-Myers Squibb is arriving at promising support. More 

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today. More 

BMY Stock: It’s Time to Buy Bristol-Myers Squibb Co

Following a failed cancer drug approval, BMY stock dropped nearly 16%. That appears to be an overreaction, so time to take a bullish stance. More 

Why Bristol-Myers Squibb Co (BMY), Liberty Interactive Corp (QVCA) and Royal Bank of Scotland Group PLC (RBS) and Are 3 of Today’s Worst Stocks

Bristol-Myers (BMY), Liberty Interactive (QVCA) and Royal Bank of Scotland (RBS) never even had a chance of bullishness on Friday. More 

3 Big Stock Charts for Friday: Bristol-Myers Squibb Co (BMY), Merck & Co., Inc. (MRK) and Fitbit Inc (FIT)

Huge news changes the technical outlook for Merck (MRK) and Bristol-Myers (BMY) while the long-term picture favors the bulls for Fitbit (FIT). More